The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
ATM protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein]; PARP1 protein affects the reaction [4-amino-1,8-naphthalimide results in increased phosphorylation of ATM protein] ATM protein affects the susceptibility to 4-amino-1,8-naphthalimide
4-amino-1,8-naphthalimide promotes the reaction [arsenic trioxide results in increased expression of CASP3 protein]; 4-amino-1,8-naphthalimide promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] 4-amino-1,8-naphthalimide results in increased activity of CASP3 protein
4-amino-1,8-naphthalimide inhibits the reaction [arsenic trioxide results in decreased expression of CCNB1 mRNA]; 4-amino-1,8-naphthalimide inhibits the reaction [arsenic trioxide results in decreased expression of CCNB1 protein]
4-amino-1,8-naphthalimide results in increased phosphorylation of CHEK2 protein PARP1 protein affects the reaction [4-amino-1,8-naphthalimide results in increased phosphorylation of CHEK2 protein]
4-amino-1,8-naphthalimide inhibits the reaction [Doxorubicin results in increased activity of PARP1 protein] 4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein ATM protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein]; PARP1 protein affects the reaction [4-amino-1,8-naphthalimide results in increased phosphorylation of ATM protein]; PARP1 protein affects the reaction [4-amino-1,8-naphthalimide results in increased phosphorylation of CHEK2 protein]; PRKDC protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein] 4-amino-1,8-naphthalimide results in decreased expression of PARP1 protein
PRKDC protein affects the susceptibility to 4-amino-1,8-naphthalimide PRKDC protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein]
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [ABCG2 protein results in increased uptake of lucifer yellow]; Novobiocin inhibits the reaction [ABCG2 protein results in increased uptake of lucifer yellow]; Omeprazole inhibits the reaction [ABCG2 protein results in increased transport of lucifer yellow]